TAG:
laboratory companies
Dr Lal PathLabs, Malpractice Costs, Med Tech Strike in New Zealand
By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue
BOSTON INVESTORS PURCHASE INTEREST IN DR LAL PATHLABS PATHOLOGY AND CLINICAL LABORATORY COMPANIES IN INDIA continue to attract investor interest. Last month, TA Associates, a private equity firm in Boston, Massachusetts, announced that it had purchased a minority interest in…
More Hospitals Consider PAML’s Lab JV Model
By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue
CEO SUMMARY: One joint venture at a time, PAML is convincing hospital and health system CEOs about the benefits of building a thriving laboratory outreach business. For their part, facing budget cutbacks and a decline in Medicare reimbursement, more hospital administrato…
Labs Hope to Renegotiate 1.75% Medicare Fee Cuts
By Robert Michel | From the Volume XVII No. 12 – August 23, 2010 Issue
CEO SUMMARY: As Congress crafted its reform of the nation’s healthcare system last year, it asked healthcare providers to contribute substantially to the cost of the Patient Protection and Affordable Care Act. The lab industry will see a 1.75% cut in reimbursement for Medicare …
AAB’s Suit Prevails over NY State Following 11 Years of Litigation
By Robert Michel | From the Volume XVII No. 11 – August 2, 2010 Issue
SCORE A BIG WIN FOR THE GOOD GUYS! An appeals court in New York state has upheld a lower court ruling that the New York State Department of Health (NYSDOH) intentionally overcharged clinical laboratories for the costs of regulating clinical laboratories and blood banks, possibly goin…
Specimen Volume Declines Reported By Quest Diagnostics and LabCorp
By Robert Michel | From the Volume XVII No. 11 – August 2, 2010 Issue
IN REPORTING SECOND QUARTER EARNINGS, there was enough difference in the numbers announced by Quest Diagnostics Incorporated and Laboratory Corporation of America to catch the attention of financial analysts. Revenue at LabCorp was up for the quarter while revenue a…
In South Carolina, TC/PC May Be “Misconduct”
By Robert Michel | From the Volume XVII No. 10 – July 12, 2010 Issue
CEO SUMMARY: Last month, the South Carolina Board of Medical Examiners advised all physicians in the state that certain arrangements for technical component/professional component (TC/PC) services between referring physicians and pathologists may be in violation of state law. The…
California’s Legal Challenge to Discount Pricing
By R. Lewis Dark | From the Volume XVII No. 8 – June 1, 2010 Issue
PROBABLY NO TOPIC IN THE LAB TESTING INDUSTRY generates more controversy than discounted pricing for physicians, managed care companies, and IPAs (independent physician associations). Almost every pathologist and laboratory executive decries the corrosive effects of below-cost pricing. Yet, many of …
June 1, 2010 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVII No. 8 – June 1, 2010 Issue
Kaiser Permanente Northern California says it now has all 21 hospitals and 160 clinics and medical offices up and running with a fully functioning electronic health record (EHR) system. This ends implementation of a decade-long effort that cost $4 billion. Kaiser claims that its Heal…
Did Wrong Strategy Sink Westcliff Medical Labs?
By Robert Michel | From the Volume XVII No. 8 – June 1, 2010 Issue
CEO SUMMARY: All sorts of people will argue all sorts of opinions about the financial demise of BioLabs, Inc., and its subsidiary, Westcliff Medical Laboratories, Inc., and why it ended up in a California bankruptcy court. Documents filed in the case indicate that, from the birth…
Westcliff Labs Announces BK and Sale to LabCorp
By Robert Michel | From the Volume XVII No. 8 – June 1, 2010 Issue
CEO SUMMARY: Subject to court approval, Laboratory Corporation of America is poised to acquire the assets of California-based Westcliff Medical Laboratories, Inc., which just filed a Chapter 11 bankruptcy action in federal court on May 19. In a separate transaction, LabCorp has a…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized